remained stable and rcp decreased from 20 ± 10 to 16 ± II mm Hg (p < 0.001). A decrease in ICP of more than 20% below the baseline value was observed in 77.2, 5.5, and 48.8% of hyperventilation, induced-hypertension, and metabolic suppression tests, respectively (p < 0.001 for all comparisons). Predictors of an effective reduction in ICP included a high PaC0 2 for hyperventilation, a high study GCS score for induced hypertension, and a high PaCO, and a high CBF for metabolic suppression.
Conclusions. Of the three modalities tested to reduce ICP, hyperventilation therapy was the most consistently effec tive, metabolic suppression therapy was variably effective, and induced hypertension was generally ineffective and in some instances significantly raised ICP. The results of this study suggest that hyperventilation may be used more aggressively to control ICP in head-injured patients, provided it is performed in conjunction with monitoring of SjvO,.
KEy WORDS hyperventilation therapy induced-hypertension therapy pressure autoregulation metabolic suppression therapy propofol transcranial Doppler ultrasonography traumatic brain injury vasoreactivity F OR the past three decades, commonly used therapies these five therapies, hyperventilation, metabolic suppres for the reduction of ICP in a patient who has incurred sion, and CPP therapy remain the most controversial. Their head injury have included hyperventilation, ventricu relative effectiveness and the factors that may lead to a lar drainage of cerebrospinal fluid, osmotherapy with man greater improvement in ICP or CPP with each of these nitol, and metabolic suppression therapy. 6.11.12,19,21,32 ,41 More therapies have not been well defined. Furthermore, each of recently, maintenance of an adequate CPP, so-called CPP -these treatments has potential deleterious effects for brain therapy, as described by Rosner and colleagues 4 6.47 has also injured patients. Results from some studies indicate that ex been used as a means of improving or stabilizing ICP. Of cessive hyperventilation has been associated with reduced SjvO, and brain tissue oxygenation and poorer long-term outcome after severe hcad injury.36.51.61 Use of metabolic suppression therapy with high-dose pentobarbital or propo fol may also be associated with serious systemic compli cations.1556.62 Aggressive CPP therapy with intravascular volume expansion and vasopressor agents can lead to pul monary edema and end-organ ischemia. llA ] With these issues in mind, we endeavored to determine the relative efficacy of hyperventilation, CPP, and metabol ic suppression therapies in improving ICP in intubated head-injured patients. Assessment of these three treatment modalities was performed during bedside vasoreactivity testing for COl reactivity, pressure autoregulation, and met abolic suppression reactivity by using TCD ultrasonogra phy. An additional goal of this study was to identify factors that were predictive of an effective reduction in ICP.
Clinical Material and Methods

Patient Enrollment and Ethical Considerations
Transcranial Doppler ultrasonography and I33Xe CBF monitoring are routinely used in the acute care of moder ately and severely head-injured patients at UCLA and Har bor-UCLA Medical Centers. The vasoreactivity test battery described later was initiated to help optimize management of ICP and CPP, and was subsequently formalized into a prospective study in which the testing frequency was in creased and additional metabolic data from jugular bulb catheters were collected. This report includes data from 28 patients who were recently described in terms of their re sponses to serial vasoreactivity testing. 19 Five additional pa tients have since been emolled in the current studv and their data are included in this report:. Of the total cohort of 33 patients, the last 23 were prospectively emolled in the vaso reactivity study and the first 10 patients were tested for clin ical indications. The institutional review boards of both the UCLA and Harbor-UCLA Medical Centers approved our research protocol.
Inclusion and Exclusion Criteria
Eligible patients included those aged 16 years or older, who had sustained a closed or penetrating traumatic brain injury with a postresuscitation (or delayed deterioration) GCS-" score of 3 to 12, and who required mechanical ven tilation therapy and ICP monitoring. Patients were exempt ed from the study when they were extubated or were able to follow commands. Patients did not receive mannitol, or have changes in sedative doses or vasopressor therapy for at least 1 hour prior to beginning the study. Patients were studied only if they were incapable of following commands and had stable cardiovascular and pulmonary systems.
Patient Management
All patients were admitted to the intensive care unit after initial stabilization or after emergency craniotomy for evac uation of an intracranial hematoma. t Percent of studies with abnonnal vasoreaerivitv. Nomlal CO. reactivity is defined as 3.7 :!: 0.5%/mm Hg PaCO.; nonnal pressure autoregulation is defined as a PAl greater than 70%: and nonnal metabolic suppression is de fined as a decrease in COo-corrected V"o of 30% or more after the patient has undergone administration of high-dose propofol. according to Lee. et al.
::: Of the baseline "'Xe CBF studies. data from one study (1.8%) demon strated global ischemia, which was de tined as global CBF lower than 20 mV 100 g/min, and data from 10 studies (18%) showed absolute hyperemia. which was defined as global CBF higher than 55 ml/lOO g/min, according to Kelly. et al.. 1996. and Obrist, et al.
MABP, CPP. SjvO" PaCO" ETCO" jugular venous CO" CMRO" AVDO" CMRglu, and AVDglu as well as the de rived values for CO, reactivity, PAl, and metabolic sup pression reactivity. Predictors were considered to be signif icant if they were associated with a decrease in ICP of 20% or more.
Statistical Analysis
In this study, we report the results of individual vasore activity tests; however, intraindividual correlation must be considered when correlations are calculated between pa rameters. The change in ICP was stratified quantitatively and qualitatively. The odds of achieving this goal were cal culated for each of the tested modalities. To define predic tors of success for a given therapy. mixed-effects logistic regression analysis was performed and the Pearson corre lation coefficient was calculated. For all statistical tests, a difference was detined as significant when the probability value was less than 0.05. Table 1 shows the results of the global tests for baseline CBF, CO 2 reactivity, pressure autoregulation, and metabol ic suppression reactivity. Table 2 and t Probability values were calculated using the paired t-test for dependent variables, but their calculation did not take into account the presence of oth er contributing factors.
Results
Hyperventilation Therapy
+An SjvO, less than 55% did not occur in any of these studies. An SjvO, less than 60% occurred in 24.2% of (8 of (p < 0.001); Sjv0 2 had a mean increase from 72 ::!:: 7 to 74:::t:: 9% (p < 0.001). In only three studies (5.5%) did ICP decrease more than 20% from its baseline value, whereas in 35 studies (63,6%) ICP changed no more than 20%, and in 17 studies (30,9%) ICP increased more than 20%. 11 (52.4%). In 10 studies in which rcp remained above 20 mm Hg after hyperventilation therapy. baseline ICP was, on average, very high with a mean value of 37 2: 11 mm Hg. With hyperventilation ti1erapy, there was no correlation be tween percentage change in rcp and postinjury day. The calculated CO, reactivity on the day of the study also did not correlate with the degree of decrease in ICP, although CO, reactivity was generally intact (mean value 3. Induced-Hypertension Therapy. Of all assessed factors, only the patient's GCS score prior to initiating the study correlated inversely with a reduction in rCp. In patients with a study GCS score of 3 or 4, rcp increased from a mean of 31.2%, P = 0.055).
Metabolic Suppression Therapy
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Discussion
Overview of Findings
The purpose of this study was to define the relative effec tiveness of three commonly used therapies to reduce ICP, namely hyperventilation, induced hypertension, and meta bolic suppression. OveralL ICP was reduced in 96.5, 34.6, and 79.1 % of studies with hyperventilation. induced hyper- tension, and metabolic suppression therapies, respectively, and effective ICP reduction, defined as a decrease of more than 20%, was seen in 77.2, 5.5, and 48.8% of studies, re spectively. Interestingly, in 31 % of studies, induced hyper tension resulted in an increase in ICP of more than 20% from its baseline value. Induced hypertension was useful in decreasing ICP only in patients with relatively higher study GCS scores. Metabolic suppression was most effec tive in loweling ICP when baseline global CBF, PaCO" and CMRO, were relatively elevated. Hyperventilation therapy was most effective when baseline PaCO, was higher. The clinical significance and pathophysiological implications of these findings are discussed later.
Methodological Issues
The nature of this study carries with it a selection bias for comatose head-injured patients with relative cardiopul monary stability. When patients were capable of following commands, they were exempted from the study. Likewise, when they expeIienced hemodynamic or pulmonaJy insta bility, or when ICP was extremely labile, vasoreactivity tests were postponed. Nonetheless, the patients studied rep resent a fairly typical spectrum of severely and some mod erately head injured patients. Regarding data analysis, the decision to present the data by individual study response as opposed to individual patient response was based on the fact that ICP treatment in head-injured patients often chang es on a day-to-day, and sometimes an hour-to-hour, basis. Nonetheless, in repeated tests in individual patients an intra individual con-elation must be assumed. The statistical eval uation incorporated a methodology that corrected for this intraindividual cOlTelation. Finally. the transient nature of these therapeutic manipulations makes conclusions regard ing their long-term impact difficult to detemline. For exam ple, in this study we did not specifically address how long the beneficial Iep effects of hyperventilation may last.
Hypen'enrilarwn Therapy
Hyperventilation therapy has been used for almost three decades as a means of treating intracranial bypeI1ension.
48A ')
It is widely assumed that the hyperventilation-induced de- 36 Results of more recent studies demonstrate that the lisk of "aggressive hy perventilation" to a PaCO, of less than 25 mm Hg has prob ably been overstated given that global ischemia (defined as an SjvO, < 55%) has been rarely rep0l1ed.
25s
That hyperventilation may also be safe on a local brain level was recently supported by data from a study in which cerebral microdialysis was perfo1Tl1ed in pericontusional brain during hyperventilation trials in severely head injured patients. Only minor elevations in periconrusional gluta mate levels and the lactate/pyruvate ratio OCCUlTed during hyperventilation therapy, presumably because of the severe local impairment in CO, reactivity around the contusions. 3D
Data from the present study indicate that hyperventila tion therapy is a highly effective means of reducing ICP in the majOlity of head-injured patients, at least transiently. and that it can be perfonned safely if done in conjunction with SjvO, monitoring.43.53 Hypocapnia may be most useful during the posttraumatic hyperemic phase of brain injury, which generally occurs beyond the 1st day postinjury, lasts until postinjury Day 4 or S, and is often associated with pe Iiods of marked intracranial hypertension. 2425 .33 Given that the vasoconstrictor effect of hyperventilation on pial arteri oles diminishes after 24 bours,37 sustained hyperventilation should be avoided ifICP is nonnaP6 Hyperventilation dur ing the first 6 to 12 hours postinjury when CBF is lowest should also be induced with caution. 
Induced-Hypertension Therapy
Based on the theory of Lundberg's31 plateau and B-waves. Rosner and colleagues-lW developed the concept of CPP management. This concept assumes the presence of a "vasoconstrictionlvasodilatory cascade" in which a de 'ax ,.,in crease in blood pressure or CPP results in arteriolar vasodi lation, thus increasing CBV, which in turn increases ICE In contrast, an increase in blood pressure causes an increase in CPP that triggers arteriolar constriction, and consequent and, on average, propofol-induced burst suppression result ed in a 21 t)f: fep reduction. This finding is notable given that metabolic suppression reacti vity was below nonnal in 88.4% of the tests. Propofol-induced ICP reduction is like ly to be related to two possible mechanisms. The first and most well accepted is the ability of propofol to decrease ce rebral metabolism. As demonstrated in animal studies, with intact coupling of metabolism and blood flow, CBF· and CBV are both decreased, leading to a drop in ICp'611 Alterna tively, when metabolic blood-flow coupling is impaired, as was the case in the majority of patients in this study, admin istration of high-dose propofol nonetheless causes a global reduction in bodily metabolism and CO, production. Be cause of preserved CO, reactivity, this propofol-induced systemic hypocapnia likely leads to vasoconstriction and ICP reduction despite impaired metabolic reactivity. In this study, predictors of effective ICP reduction with the use of high-dose propofol included a high baseline PaC0 2 and CBF. The metabolic effects of propofol were, on average, decreases in CBF, CMRO" and CMRglu by a mean 16, 11, and 18%, respectively, reductions less than those observed in nonnal animals. I.5 This blunted metabol ic response is likely related in part to the fact that cerebral oxidative and glucose metabolism are already markedly de pressed after head injury.7,.j(] Additionally, by maintaining a stable blood pressure during propofol infusion in this study, the hypotensive effect often seen with propofol or pentobar bital was eliminated, thereby reducing the overall decrease seen in CBF, CMRO" and CMRglu. 14 . 63
Clinical Implications
In our recent study in which we assessed acute vasore activity changes in patients during the first 2 weeks after moderate or severe head injury. CO 2 reactivity remained relatively intact. autoregulation was variably impaired, and metabolic suppression reactivity was severely impaired. 29 In the present study, the resilience of CO 2 reactivity appears to translate into an effective means ofICP reduction, where as the high degree of impaired pressure autoregulation translates into the frequent observation of a pressure-pas sive cerebral vasculature with blood pressure-induced ICP elevations. In contrast, the severe impainnent of metabolic suppression vasoreactivity does not necessarily equate with the failure of this therapy in reducing ICP. This seeming ly paradoxical observation likely occurs because of propo fol-induced bodily hypocapnia and a resultant decrease in ICP. It is reasonable to assume that a similar bodily effect on PaCO, occurs with the administration of high-dose pen tobarbital.
Although the importance of maintaining an adequate CPP after head injury has been stressed during the last dec ade,3. predictor of poor long-tenn outcome and that no benefit oc curred by maintaining CPP above 60 mm Hg.21 Data from these two studies in which investigators assessed outcome in relation to CPP and results of th~ present study in which
we assessed the acute impact of blood pressure elevation on ICP indicate that induced hypertension to improve CPP and ICP should be pelfonned with caution. In contrast. given that hyperventilation has been shown to be both safe and effective in reducing ICP in this study and others. its more routine use to levels below 30 mm Hg is probably rea sonable during periods of intracranial hypertension beyond the first 6 to 12 hours postinjury. An additional advantage of moderate hyperventilation is that it may help to restore nonnal pressure autoregulation in head-injured patients. al though this effect may be transient,38
To maximize the utility and minimize the risks of hy perventilation. induced hypertension. and metabolic sup pression therapies. SjvO: monitoring is recommended for head-injured patients at risk for intracranial hypeltension. Inseltion of jugular bulb catheters is a relatively safe proce dure in the hands of experienced intensivists and neurosur geons. (Table 6 ).
Conclusions
In this study we compared three commonly used meth ods of ICP control. namely hyperventilation therapy. in duced hypeltension. and metabolic suppression therapy. Hyperventilation was consistently effective. induced hyper tension was consistently ineffective. and metabolic suppres sion therapy was valiably effective. These findings SUPPOI1 the more frequent use of hyperventilation in controlling in tracranial hypenension after head injury. provided that ap propriate monitOling of SjvO: is peJfOlmed. 
